The Top 20 Global Pharmaceutical Companies by Sales

The table below lists the top 20 global drug companies based on sales in 2009:

S.No.CompanyTicker2009 Revenues in US $ (Milllions)
1PfizerPFE$45,448
2Sanofi-AventisSNY$40,871
3NovartisNVO$38,455
4GlaxoSmithKlineGSK$36,746
5AstraZenecaAZN$31,905
6Merck & Co.MRK$26,929
7Johnson & JohnsonJNJ$22,520
8Eli Lilly & Co.LLY$20,629
9Bristol-Myers SquibbBMY$18,808
10Abbott LaboratoriesABT$16,486
11Takeda Chem Ind.TKPYY$14,204
12Boehringer-Ingelheim $14,027
13Teva PharmaTEVA$13,814
14Bayer ScheringBAYRY$13,344
15Astellas $10,509
16Daiichi-Sankyo $9,757
17EisaiESALY$8,441
18Otsuka $7,717
19Gilead SciencesGILD$6,469
20MylanMYL$5,015

Source: Contract Pharma

Otsuka, Gilead and Mylan are new to this list. Half of the companies ranked 11-20 are based in Japan. Though currently ranked at number 13, Israel-based Teva (TEVA), the world’s largest generic drug maker, has revenue goals that could propel it into the top 7 ranks in the next few years. US-based Gilead (GILD) primarily focuses on developing drugs for life-threatening diseases diseases such as HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.

Related:

The Top 10 Global Biopharmaceutical Companies by Sales

More on this topic (What's this?)
I Lost My Job
Read more on Wheelock & CO, Drug Manufacturers - Major, Gilead Sciences at Wikinvest

Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically to your feed reader.

Comments

[...] few days ago we reviewed the top 20 global pharmaceutical companies by sales. In this post, lets take a quick look at the top 10 global biopharmaceutical firms based [...]

[...] few days ago we reviewed the top 20 global pharmaceutical companies by sales. In this post, lets take a quick look at the top 10 global biopharmaceutical firms based [...]

Hello David,

this ranking is bizarre

Roche is a Global pharma, isn’t it ? I do not agree with the guys from Contract Pharma when they get Roche in a different ranking (“Biopharma”)

Sales 09 (Roche): 49,051 Swiss francs($43,623)

Regards,sacha

Sacha
Yes.I was not sure either why they did that.Only thing that was mentioned was the Genentech takeover.I have always thought of Roche as a global pharma company.

Let me send them an email and see what they respond regarding this issue. Thanks for your comment.

-David

Leave a comment

(required)

(required)